 |
|
 |
 |

Home > Company Index > Chemicals > Diversified Chemicals > Genencor International, Inc.
 |
Genencor International, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Xenova signs $105 mln deal for cancer drug Aug 13 2001 10:57 PM PDT
Novozymes at 3-mth low on Genencor news Aug 03 2001 06:16 AM PDT
Genencor 2nd-qtr profit, full year estimate, drop Aug 02 2001 01:44 PM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Genencor International manufactures genetically modified enzymes for clients in the industrial, agricultural, and health care markets. Using gene discovery, molecular evolution and design, and functional genomics, the company finds genes and alters their proteins for use in cleaning products, textiles, health care products, and enhanced grain and animal feed. Genencor is developing enzymes for use in skin care products through a partnership with Proctor & Gamble (which accounts for 30% of sales); and it is crafting a low-cost production method for vitamin C with Eastman Chemical Co. About 54% of Genencor's product sales are outside the US. Eastman Chemical and Danisco each own about 40% of Genencor.
COMPETITION |
 |
DSM N.V. (DSMKY)
Enchira Biotechnology Corporation (ENBC)
Novo Nordisk A/S (NVO)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 316.20
1-Yr. Sales Growth: (0.1)%
Employees: 1,533
Revenue per employee: $206,262.23
KEY PEOPLE |
 |
W. Thomas Mitchell
CEO
Raymond J. Land
CFO
CONTACT INFO |
 |
925 Page Mill Rd.
Palo Alto, CA 94304
US
Phone: 650-846-7500
Fax: 650-845-6503
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |